| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/28/2011 | US20110183948 Treatment of fibrotic conditions using hedgehog inhibitors |
| 07/28/2011 | US20110183928 3-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereof |
| 07/28/2011 | US20110183889 Salicylanilide modified peptides for use as oral therapeutics |
| 07/28/2011 | US20110182913 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | CA2786866A1 Hydrogel of microspheres |
| 07/28/2011 | CA2785521A1 Compositions including pyruvate for companion animals and methods of use thereof |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2029134B1 Stabilized pharmaceutical compositions comprising fesoterodine |
| 07/27/2011 | EP1744746B1 Use of melatonin in preventing postoperative complications |
| 07/27/2011 | EP1598349B1 Novel 2-pyridinecarboxamide derivatives |
| 07/27/2011 | CN1964979B Novel water-soluble prodrug |
| 07/27/2011 | CN102137863A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137660A Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8 |
| 07/27/2011 | CN102134231A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134229A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102133353A Traditional Chinese medicine composition for treating nephritic syndrome and application method thereof |
| 07/27/2011 | CN102133335A Method for detecting quality of niaolukang particles |
| 07/27/2011 | CN102133308A Capsule for removing toxin and eliminating fat |
| 07/27/2011 | CN102133302A Verbena extract extracted from verbena and used for curing prostatitis |
| 07/27/2011 | CN102133285A Method for preparing kidney-tonifying and body-strengthening capsules |
| 07/27/2011 | CN102133272A Preparation method of granules for treating nephrolith |
| 07/27/2011 | CN102133268A Quality control method of medicinal material |
| 07/27/2011 | CN102133263A Preparation method and application of eupatorium japonicum extract |
| 07/27/2011 | CN102133246A Preparation method of andrographis paniculata capsules |
| 07/27/2011 | CN102133196A Potassium ion binding polymers for pharmaceutical compositions |
| 07/27/2011 | CN102133180A Long-acting injection preparation of sterides 5 alpha-reductase inhibitor and preparation method thereof |
| 07/27/2011 | CN101843695B Chinese medicament for treating chronic kidney failure |
| 07/27/2011 | CN101785776B Application of ergot sterone in preparation of medicaments for treating chronic renal failure |
| 07/27/2011 | CN101780188B Capsule for treating prostatic diseases |
| 07/27/2011 | CN101766734B Medicine for treating prostatitis |
| 07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
| 07/27/2011 | CN101336983B Oldenlandia and quality control method of preparation containing oldenlandia |
| 07/27/2011 | CN101313943B Chinese medicinal composition for treating nephropathy and preparation thereof |
| 07/27/2011 | CN101249176B Chinese medicine prescription for steaming and soaking foots |
| 07/27/2011 | CN101244240B Quantitative and qualitative analysis method for four turmeric soup preparations |
| 07/26/2011 | US7985772 Derivatives of 3,3-diphenylpropylamines |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | CA2603185C Propane-1,3-dione derivative or salt thereof |
| 07/26/2011 | CA2445344C Heterocyclic compound derivatives and medicines |
| 07/21/2011 | WO2011087102A1 Therapeutic agent for promoting recovery of animal under medical treatment |
| 07/21/2011 | WO2011086507A1 "compositions comprising amino acids for prevention and/or treatment of renal disorders" |
| 07/21/2011 | WO2011086077A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | US20110178294 Novel carboxylic acid derivatives, their preparation and use |
| 07/21/2011 | US20110178141 Thiazoliums and Their Use for Treating Protein Aging Associated Diseases |
| 07/21/2011 | US20110178103 Therapeutic agent for chronic renal failure |
| 07/21/2011 | US20110178088 Tetrahydro-naphthalene derivatives |
| 07/21/2011 | US20110178082 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178081 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178060 Nitrogen-containing heterocyclic compound and use of same |
| 07/21/2011 | US20110178020 Methods and compositions for inhibition of neutrophil exocytosis |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177173 Compounds as l-cystine crystallization inhibitors and uses thereof |
| 07/21/2011 | US20110177133 Use of opioid antagonists for treating urinary retention |
| 07/21/2011 | US20110177046 Dithiazolidine and thiazolidine derivatives as anticancer agents |
| 07/21/2011 | CA2799474A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2786764A1 Compositions comprising amino acids for prevention and/or treatment of renal disorders |
| 07/20/2011 | EP2345644A1 Indazole compound |
| 07/20/2011 | EP2345415A1 Therapeutic/prophylactic agent for prostate cancer |
| 07/20/2011 | EP2345410A1 Controlled release pharmaceutical composition |
| 07/20/2011 | EP2344528A1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 07/20/2011 | EP2344501A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| 07/20/2011 | EP2344493A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/20/2011 | EP2344492A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/20/2011 | EP2344162A2 5ht7 receptor ligands and compositions comprising the same |
| 07/20/2011 | EP2091927B1 Thiazole and oxazole-substituted arylamides |
| 07/20/2011 | EP1482920B2 Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 07/20/2011 | EP1361884B1 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 07/20/2011 | CN102127071A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127057A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127053A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127023A 7-membered ring compound, process for producing the same, and use thereof |
| 07/20/2011 | CN102125667A Traditional Chinese medicament for treating pyretic stranguria caused by heart-fire hyperactivity transferring pathogenic moist heat to small intestine |
| 07/20/2011 | CN102125659A Enema for treating prostatic diseases |
| 07/20/2011 | CN102125610A Xiaojin sustained-release pellets and composition thereof |
| 07/20/2011 | CN102125605A Urinary system kidney tonifying and stone discharging Chinese medicine preparation |
| 07/20/2011 | CN102125546A Composition for preventing kidney stone |
| 07/20/2011 | CN102125543A Heparin-free anticoagulant infection inhibitor for hemodialysis and preparation method thereof |
| 07/20/2011 | CN101850078B Chinese medicament for treating chronic nephritis |
| 07/20/2011 | CN101843876B Chinese medicinal composition for preventing renal cell apoptosis and anemia caused by cis-platinum (DDP) and preparation method thereof |
| 07/20/2011 | CN101843750B Chinese medicament for treating chronic nephritis |
| 07/20/2011 | CN101804181B Traditional Chinese medicine preparation for treating prostatitis and preparation method thereof |
| 07/20/2011 | CN101690740B Calculi dissolving agent for treating urologic calculi |
| 07/20/2011 | CN101628060B Medicinal decoction used for treating prostate hyperplasia |
| 07/20/2011 | CN101347490B Extract of rape pollen with broken wall and purification method and use thereof |
| 07/20/2011 | CN101305007B Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as PDE5 inhibitors |
| 07/20/2011 | CN101250134B N-aryl-beta-aryl amidine-propionamide compounds, preparation method and use thereof |
| 07/20/2011 | CN101234147B Method of preparing total flavones of tropaeolum for injections |
| 07/20/2011 | CN101084911B Notoginsenoside sodium freezing-dried emulsion and preparation method thereof |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7982015 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981419 Method for treating hypophosphatemic bone diseases using FGF-23 antibody |
| 07/19/2011 | CA2485503C Phenyl-thiophene type vitamin d receptor modulators |
| 07/19/2011 | CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/19/2011 | CA2459165C Dosage forms having prolonged active ingredient release |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2440890C Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |